We offer a suite of cell-based assays, including cytotoxicity assays, cell apoptosis and necrosis assays, and cell-binding assays, to characterize GPA33's biological function. These are essential for measuring therapeutic efficacy and validating the specificity of drug candidates.
GPA33 Assay Portfolio Service
Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Creative Biolabs' service provides a turnkey solution for researchers and biopharmaceutical companies targeting GPA33. Creative Biolabs offers specific deliverables and key problem-solving capabilities, including the precise characterization of GPA33 expression in both colorectal cancer and Barrett's metaplasia. Our assays are designed to help you navigate the complexities of GPA33's expression patterns and provide the tools needed to investigate its regulatory pathways, including the WNT, PPARγ-KLF4, and CDX1 axes.
GPA33 and Regulatory T Cells
GPA33 is a cell-surface glycoprotein predominantly expressed in the colon and small intestine, making it a key biomarker for colorectal cancer and related gastrointestinal conditions. Recent literature has revealed its intricate regulatory landscape, with its expression influenced by pathways such as WNT, PPARγ-KLF4, and CDX1. Studies have also identified GPA33 as a prognostic indicator for CRC and a specific marker for Barrett's metaplasia.
Discover how we can help - Request a consultation.
What We Can Offer
GPA33 Functional Assays
Multi-level Expression Analysis
Our portfolio provides robust methods for quantifying GPA33 at both the mRNA and protein levels. This includes Northern blot and Western blot analysis for precise size and quantity determination, as well as flow cytometry analysis and IHC for cellular and tissue-level localization.
Advanced Mechanistic Studies
To fully understand GPA33's role in cellular processes, we offer specialized assays such as the biotinylation turnover assay, which precisely measures the endocytosis and recycling rates of the GPA33 protein. This is a critical tool for developing ADCs and other targeted therapies.
Workflow of GPA33 Assay Portfolio Service
Highlights
Pre-validated & Reliable Assays
All assays in our portfolio are rigorously pre-validated, ensuring exceptional specificity, sensitivity, and reproducibility. This allows you to bypass time-consuming in-house development and move directly to generating high-quality, trusted data.
Expert Scientific Support
Our service is backed by a team of highly experienced scientists with deep expertise in GPA33 biology and immuno-oncology. We act as a true partner, providing comprehensive consultation and technical support from the initial project design to the final data interpretation.
Comprehensive Multi-faceted Approach
We offer a diverse portfolio of assays to provide a complete picture of GPA33. By combining methods like RT-PCR for gene expression and IHC for protein localization, we help you build a robust, multi-level understanding of your target.
In-depth Mechanistic Insights
We offer specialized assays to investigate critical regulatory pathways (e.g., WNT, PPARγ-KLF4, and CDX1 axes) and functional assays to study processes like endocytosis and cytotoxicity, which are essential for developing advanced therapeutic strategies.
Experience the Creative Biolabs advantage - Get a quote today.
Customer Reviews
-
Crucial Insights
Creative Biolabs has significantly improved our ability to characterize the complex intratumoral heterogeneity of this marker. The data were critical for our understanding of disease progression, particularly the loss of antigen expression at the infiltrative tumor edge. - Dr. Js H**s.
-
Streamlined Our Research
The pre-validated nature of the Creative Biolabs service streamlined our investigation into the PPARγ-KLF4 pathway. We were able to get reliable and reproducible GPA33 expression data, which saved our lab months of work and countless resources. - S*h M.
FAQs
What types of samples are compatible with your GPA33 assays?
Our comprehensive portfolio is designed for versatility. We can work with a wide range of samples, including fresh-frozen or FFPE tissue sections for IHC, blood samples (serum, plasma) for ELISA, and cell cultures for flow cytometry and RT-PCR.
Can your assays be used to study GPA33's gene regulation pathways?
Absolutely. Our RT-PCR and flow cytometry assays investigate GPA33 regulatory mechanisms by measuring changes in mRNA and protein expression in response to pathway modulators, helping you validate hypotheses about pathways like the WNT, PPARγ-KLF4, and CDX1 axes.
Related Services
Cell Line Development Service
We can create custom cell lines with knockout, knockdown, or overexpression of GPA33, KLF4, or CDX1.
Learn More →Antibody and Protein Production
We offer full-spectrum antibody development, ensuring high specificity and affinity for your intended application.
Learn More →How to Contact Us
Are you currently facing long biomarker characterization cycles or difficulties in understanding complex gene regulation pathways? Our GPA33 assay portfolio service helps you accelerate drug discovery and streamline research by providing a suite of pre-validated assays.
Contact us for more information and to discuss your project.
Download our brochureLoading case studies...
Online Inquiry